Location: Home
  • search
  • go
  • Relate News
  • 11/15/2021CDE Solicits Comments for the Proposed Technical Guidelines for Clinic...
  • 11/15/2021Milestone's Chinese Partner Files Chinese IND for Etripamil
  • 11/15/2021NMPA Issues the List of Reference Formulations for GQCE Studies (48th ...
  • 11/15/2021China to Release the Updated NRDL Soon
  • 11/15/2021NHC Solicits Comments on Draft Revision of the Provisions for National...
  • 11/15/2021Chinese Court Rules against Kangmei Pharma in 'Milestone' Case
  • 11/15/2021FDA Closes Warning Letter to Huahai over Valsartan, Opening Door for t...
  • 11/15/2021HebaBiz Biotech's P3 Trial in China for HBV Drug Clevudine (L-FMAU) ...
  • 11/15/2021SCMP: China May Approve First Covid-19 Drug Within Weeks
  • 11/12/2021CDE Issues the Technical Guidelines for Minimal Residual Disease Detec...
  • 11/12/2021NMPA Solicits Comments on the Draft Provisions for Quality Control of ...
  • 11/12/2021AZ Reports Mixed Q3/2021 Results, As It Begins to Manage Future Expect...
  • 11/11/2021NMPA Hosts Meeting on Drug, Medical Device, Cosmetic Regulation in Chi...
  • 11/11/2021Everest Med and Gilead Announce P2b Study of Sacituzumab Govitecan in ...
  • 11/11/2021Organon Reports Q3/2021 Earnings, Highlighting China Performance
  • 11/11/2021Blueprint Medicines and Zai Lab Announce License Deal for BLU-945 and ...
  • 11/11/2021Karuna Therapeutics and Zai Lab Announce Strategic Partnership for Ka...
  • 11/11/2021Beijing Intellectual Property Court Accepts China's First Drug Patent ...
  • 11/11/2021China Clears Trials on Using mRNA Vaccine as Booster Shot
  • 11/11/2021SK Biopharm Establishes Biotech Company in China
  • 11/11/2021AffaMed Launches Digital Medicines Unit
  • 11/11/2021PharmExec: China 2021 National Reimbursement Drug List Outlook (Update...
  • 11/11/2021How Hong Kong Plays a Central Role in The Biotech Investment Boom
  • 11/10/2021South China Province Plans $94 Million HPV Vaccination Pilot Program
  • 11/10/2021NDRC and MIIT Jointly Issue the Implementation Plan for Promoting High...
  • 11/10/2021Eli Lilly's Chinese NDA for RET Inhibitor Selpercatinib Accepted
  • 11/10/2021CDR Solicits Comments for the Proposed Guidelines for Preparing Drug P...
  • 11/10/2021CPhI Survey: US Pharma Growth to Exceed Both India and China in 2022
  • 11/10/2021Merck KGaA Veteran Launches I/O Startup Marengo Therapeutics with $80M
  • 11/9/2021Biosynth Carbosynth and Shengquan Acquire Kexing Biopharma's API Plant
  • Page:106/719 Total number of articles:21546: [First][<<] [104] [105] [106] [107] [108] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group